| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-1,986.5350 | -3,347.3760 | -1,305.9120 | -810.4230 | -868.2780 |
|
Research and Development Expenses
|
-4,093.1170 | -4,603.0020 | -2,341.6000 | -1,671.6770 | -1,949.2010 |
| Other Income/Expense, Operating
|
-337.3740 | -337.3740 | -140.5390 | -- | -- |
|
Operating Income/Expenses
|
-6,499.8440 | -8,287.7520 | -3,788.0510 | -2,482.1000 | -2,817.4790 |
|
Total Operating Profit/Loss
|
-6,499.8440 | -8,287.7520 | -3,788.0510 | -2,482.1000 | -2,817.4790 |
| Total Net Finance Income/Expense
|
-495.4490 | -405.8990 | -262.7210 | -128.9390 | 28.2750 |
| Net Investment Income
|
-3.4280 | -5.5480 | -3.0310 | -1.8850 | -2.0300 |
| Irregular Income/Expenses
|
-79.3440 | 18.6230 | -18.8150 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-578.2210 | -392.8240 | -284.5670 | -130.8240 | 26.2450 |
|
Pretax Income
|
-7,078.0650 | -8,680.5760 | -4,072.6180 | -2,612.9240 | -2,791.2340 |
|
Net Income from Continuing Operations
|
-7,078.0650 | -8,680.5760 | -4,072.6180 | -2,612.9240 | -2,791.2340 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-7,078.0650 | -8,680.5760 | -4,072.6180 | -2,612.9240 | -2,791.2340 |
|
Net Income after Non-Controlling/Minority Interests
|
-7,078.0640 | -8,680.5760 | -4,072.6180 | -2,612.9250 | -2,791.2340 |
|
Net Income Available to Common Stockholders
|
-7,078.0640 | -8,680.5760 | -4,072.6180 | -2,612.9250 | -2,791.2340 |
|
Diluted Net Income Available to Common Stockholders
|
-7,078.0640 | -8,680.5760 | -4,072.6180 | -2,612.9250 | -2,791.2340 |
| Basic EPS
|
-0.31 | -0.48 | -0.49 | -0.40 | -0.40 |
| Diluted EPS
|
-0.31 | -0.48 | -0.49 | -0.40 | -0.40 |
|
Basic Weighted Average Shares Outstanding
|
22,237.7840 | 18,098.5510 | 8,254.9480 | 6,984.8390 | 6,982.8790 |
|
Diluted Weighted Average Shares Outstanding
|
22,237.7840 | 18,098.5510 | 8,254.9480 | 6,984.8390 | 6,982.8790 |
|
EBIT
|
-6,582.6160 | -8,274.6770 | -3,809.8970 | -2,483.9850 | -2,819.5090 |
|
EBITDA
|
-6,037.6960 | -7,737.1000 | -3,272.3190 | -1,947.8760 | -2,283.4000 |
|
Normalized EBITDA
|
-5,184.3500 | -6,997.4270 | -3,168.5850 | -1,818.5990 | -2,024.8660 |
|
Normalized Income
|
-6,224.7190 | -7,940.9030 | -3,968.8840 | -2,483.6470 | -2,532.7000 |
|
Total Unusual Items
|
853.3460 | 739.6730 | 103.7340 | 129.2770 | 258.5340 |
|
Total Unusual Items Excluding Goodwill
|
853.3460 | 739.6730 | 103.7340 | 129.2770 | 258.5340 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 1/30/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade